About Hypertension

Everyone experiences daily events that raise their blood pressure. For most of us, these increases are temporary and have no lasting impact on our health. However, patients with hypertension face higher risks of heart attack, stroke, heart failure, kidney disease and death. Medtronic has developed a novel approach to hypertension that selectively quiets hyperactive renal nerves. Patients who suffer from chronic hypertension face a dramatically higher risk of heart attack, stroke, heart failure, kidney disease and death. Because of these risks, the disease is treated aggressively with lifestyle changes and prescription medication. Unfortunately, in half of treated patients these steps alone are not enough to control blood pressure. Additionally, some patients have a hard time tolerating the side-effects of medication. Clearly, another treatment option is needed. Renal Denervation (RDN) treatment was developed to give doctors a minimally invasive endovascular treatment to accomplish this goal.